MO-0711 Impact of operability and total metastatic ablation on outcomes after SABR for oligometastases. (May 2022) - Siva, S.; Bressel, M.; Sogono, P.; Shaw, M.; Chander, S.; Chu, J.; Plumridge, N.; Byrne, K.; Kothari, G.; Bucknell, N.; Hardcastle, N.; Kron, T.; et al.